DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Glucotrol XL (Glipizide Extended Releases) - Current Clinical Trials

 
 



Glucotrol XL Related Clinical Trials

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) [Completed]

To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets [Completed]

Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics [Completed]

Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) [Completed]

Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects [Completed]

Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA [Completed]

Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans [Recruiting]

To Demonstrate the Effect of Food on the Bioavailability of Glipizide [Completed]

A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019) [Active, not recruiting]

Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia [Recruiting]

Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets [Completed]

Effect of Exenatide on Liver and Heart Fat and Inflammation [Completed]

Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg [Completed]

Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg [Completed]

An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) [Completed]

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients [Completed]

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024) [Completed]

Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128) [Completed]

Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) [Completed]

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients [Completed]

Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) [Completed]

Study the Effects of CYP2C Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Glipizide [Completed]

Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease [Completed]

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies [Completed]

Insulin Glargine in Type 2 Diabetic Patients [Completed]

MK0767 Glipizide Comparator Cardiac Safety Study (0767-018) [Terminated]

Incretin-based Drugs and Acute Pancreatitis [Completed]

Incretin-based Drugs and Pancreatic Cancer [Completed]

Incretin-based Drugs and the Risk of Heart Failure [Completed]

Ginkgo Biloba Extract and the Insulin Resistance Syndrome [Completed]

Dyslipidemia in Type 2 Diabetes (0767-034) [Terminated]

Standard Medical Management in Secondary Prevention of Ischemic Stroke in China [Completed]

Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017